{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-017128","form_type":"8-K","ticker":"CYRX","cik":"0001124524","company_name":"Cryoport, Inc.","filed_at":"2022-02-09T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.479926+00:00","generated_at":"2026-06-27T09:29:34.971636+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Cryoport expects MVE New Prague production resumption Feb 14; $4-5M Q1 revenue impact","bullets":["Fire on Jan 25 at MVE Biological Solutions' New Prague facility halted production.","Production expected to resume week of Feb 14, 2022; full production ramp during Q1.","Revenue impact of $4-5 million limited to Q1 2022.","Insurance expected to cover majority of restoration costs and business interruption."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-017128","json":"https://secwatch.observer/filing/0001104659-22-017128.json","markdown":"https://secwatch.observer/filing/0001104659-22-017128.md","text":"https://secwatch.observer/filing/0001104659-22-017128.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1124524/000110465922017128/0001104659-22-017128-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1124524/000110465922017128/tm226004d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T09:29:34.971636+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}